U.S. Hyperbaric Oxygen Therapy (HBOT) Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

U.S. Hyperbaric Oxygen Therapy (HBOT) Market Size

• The U.S. hyperbaric oxygen therapy (HBOT) market size was valued at USD 101.98 million in 2024 and is expected to reach USD 158.89 million by 2032, at a CAGR of 5.70% during the forecast period
• The market growth is largely fueled by the growing adoption and technological progress within advanced wound care and non-invasive treatment modalities, leading to increased utilization of hyperbaric oxygen therapy (HBOT) across both inpatient and outpatient settings
• Furthermore, rising patient demand for effective, non-surgical, and accelerated healing options for chronic wounds, decompression sickness, radiation injuries, and diabetic foot ulcers is establishing HBOT as a preferred therapeutic solution. These converging factors are accelerating the uptake of hyperbaric oxygen therapy systems and services in the U.S., thereby significantly boosting the industry's growth

U.S. Hyperbaric Oxygen Therapy (HBOT) Market Analysis

• Hyperbaric Oxygen Therapy (HBOT), a treatment that involves breathing pure oxygen in a pressurized room or chamber, is gaining traction across the U.S. due to its wide applicability in treating conditions such as diabetic foot ulcers, carbon monoxide poisoning, radiation injuries, and non-healing wounds
• The rising prevalence of chronic diseases, particularly diabetes and vascular disorders, is a significant driver for HBOT demand, alongside increasing adoption in wound care centers, rehabilitation clinics, and hospitals
• The Monoplace segment dominated the U.S. hyperbaric oxygen therapy (HBOT) market with the largest revenue share of 57.6% in 2024, owing to its widespread usage in hospitals and outpatient clinics due to lower operational requirements, patient comfort, and affordability

Report Scope and U.S. Hyperbaric Oxygen Therapy (HBOT) Market Segmentation

U.S. Hyperbaric Oxygen Therapy (HBOT) Market Trends

“Technology-Driven Personalization and Intelligent Monitoring in HBOT”

• A rapidly emerging trend in the U.S. hyperbaric oxygen therapy (HBOT) market is the integration of technology-driven personalization and intelligent monitoring systems that enhance both patient safety and clinical outcomes
• Modern HBOT chambers are increasingly equipped with smart monitoring interfaces, allowing real-time tracking of oxygen levels, pressure, patient vitals, and treatment session metrics, improving the precision of therapy administration
• For instance, several advanced monoplace and multiplace HBOT systems now come with digital touchscreen controls, programmable treatment protocols, and automated logging, enabling clinicians to tailor therapy based on patient response patterns and underlying conditions
• Remote access technologies also allow healthcare professionals to monitor treatment progress off-site, supporting the expansion of HBOT into outpatient and home-based care models. This is especially useful for managing chronic conditions like diabetic ulcers or radiation injuries, where frequent sessions are required
• The use of integrated safety alert systems, including sensors for early detection of hypoxia or pressure irregularities, ensures a higher level of patient safety and operational efficiency. These features are proving to be highly valued in Veterans Affairs (VA) hospitals, wound care centers, and specialized clinics across the U.S.
• As patient-centric care becomes a national healthcare priority, HBOT systems offering intelligent monitoring, user-friendly interfaces, and data-driven personalization are gaining traction, not only in clinical settings but also among private practitioners seeking to enhance therapeutic efficacy and patient satisfaction

U.S. Hyperbaric Oxygen Therapy (HBOT) Market Dynamics

Driver

“Rising Demand for Advanced Wound Care and Chronic Disease Management”

• The increasing incidence of chronic wounds, diabetic foot ulcers, carbon monoxide poisoning, and radiation injuries is driving the adoption of hyperbaric oxygen therapy (HBOT) in the U.S.
• For instance, according to the American Diabetes Association, over 11% of the U.S. population suffers from diabetes, significantly contributing to the growing need for wound management solutions like HBOT, which enhances oxygen delivery to damaged tissues and accelerates healing
• Furthermore, the aging population and rising awareness among physicians regarding the clinical benefits of HBOT—such as reducing inflammation, promoting angiogenesis, and treating refractory osteomyelitis—are boosting its demand across hospitals and specialty wound care clinics
• The inclusion of HBOT in reimbursement policies by Medicare and private insurers for certain approved indications further enhances its accessibility and appeal in clinical practice
• In addition, the expansion of HBOT applications beyond traditional indications—such as for traumatic brain injury, long COVID symptoms, and sports injuries—reflects growing interest in its therapeutic versatility, contributing to broader market penetration across healthcare settings

Restraint/Challenge

“High Operational Costs and Limited Clinical Evidence for Emerging Indications”

• One of the primary challenges in the U.S. HBOT market is the high capital and operational cost associated with hyperbaric chambers, including installation, maintenance, and staffing requirements. These costs often act as a barrier for smaller outpatient clinics or rural healthcare facilities
• Multiplace chambers require dedicated infrastructure and trained personnel, which adds to the financial burden and limits scalability
• Moreover, limited robust clinical evidence supporting the efficacy of HBOT for newer, off-label indications (e.g., post-concussion syndrome, stroke rehabilitation, or autism) has led to skepticism among some healthcare providers and payers
• As a result, many of these applications are not covered under insurance plans, restricting patient access and discouraging providers from investing in advanced systems
• In addition, regulatory scrutiny and the risk of adverse effects—such as barotrauma or oxygen toxicity—require stringent protocols, which can deter broader adoption
• Overcoming these challenges will require increased clinical trials, cost-effective device innovation, and stronger reimbursement support to make HBOT a more mainstream therapeutic modality in the U.S. healthcare landscape

U.S. Hyperbaric Oxygen Therapy (HBOT) Market Scope

The market is segmented on the basis of type, application, and end user.

• By Type

On the basis of type, the U.S. hyperbaric oxygen therapy (HBOT) market is segmented into monoplace, multiplace, and topical HBOT devices. The monoplace segment dominated the market with the largest revenue share of 57.6% in 2024, owing to its widespread usage in hospitals and outpatient clinics due to lower operational requirements, patient comfort, and affordability.

The multiplace segment is anticipated to witness the fastest CAGR of 19.8% from 2025 to 2032, driven by the ability to treat multiple patients simultaneously and the demand for complex treatment settings such as military and emergency care.

• By Application

On the basis of application, the market is segmented into injuries, infection, insufficiencies, wound healing, and others. The wound healing segment accounted for the largest market revenue share of 33.4% in 2024, owing to rising chronic wound cases including diabetic foot ulcers and pressure sores.

The injuries segment is expected to register the highest CAGR of 21.2% from 2025 to 2032, due to increased use in post-surgical recovery and traumatic brain injury management.

• By End User

On the basis of end user, the market is segmented into hospitals and clinics, ambulatory surgery centers, outpatient clinics, standalone hyperbaric treatment centers, and others. The hospitals and clinics segment held the largest market share of 48.2% in 2024, due to comprehensive infrastructure, insurance coverage, and broad patient access.

The standalone hyperbaric treatment centers segment is projected to witness the fastest CAGR of 20.5% from 2025 to 2032, driven by increased demand for specialized HBOT services in urban regions.

U.S. Hyperbaric Oxygen Therapy (HBOT) Market Regional Analysis

• The U.S. hyperbaric oxygen therapy (HBOT) market dominated North America with a revenue share of 81.3% in 2024, driven by the increasing incidence of chronic wounds, carbon monoxide poisoning, decompression sickness, and radiation injuries
• The growing awareness about the clinical benefits of HBOT—such as accelerated wound healing and enhanced infection control—is significantly contributing to market growth.The U.S. market is also benefiting from the expanding network of standalone hyperbaric centers and the integration of HBOT units within hospitals and outpatient settings
• In addition, favorable reimbursement policies from Medicare and private insurers are encouraging healthcare providers to adopt HBOT as a part of standard wound care and surgical recovery protocols

U.S. Hyperbaric Oxygen Therapy (HBOT) Market Share

The hyperbaric oxygen therapy industry is primarily led by well-established companies, including:

• Gulf Coast Hyperbarics, Inc. (U.S.)
• HYPERBARIC MODULAR SYSTEMS, INC. (HMS) (U.S.)
• Newtowne Hyperbarics (U.S.)
• aha-hyperbarics (Germany)
• Sechrist Industries, Inc. (U.S.)
• Tekna Hyperbaric (Norway)
• Pan America Hyperbarics, Inc. (U.S.)
• OxyHealth (U.S.)
• Unique Group (U.A.E.)
• Fink Engineering (Australia)
• Perry Baromedical (U.S.)
• PCCI (U.S.)

Latest Developments in Hyperbaric oxygen therapy Market

• In February 2023, Western University of Health Sciences collaborated with NexGen Hyperbaric, initiating collaborative research on hyperbaric oxygen therapy. Focused on cellular studies and clinical trials, the research targets the treatment of traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD), signifying a concerted effort to explore the therapeutic potential of HBOT for both physical and mental conditions
• In February 2023, Maui Health launched a new outpatient facility in Hawaii, focusing on comprehensive care for nonhealing wounds. The facility offers hyperbaric oxygen therapy among its treatments, providing an advanced therapeutic approach
• In January 2023, Kamalaya Koh Samui in Thailand launched integrative treatments at its Longevity House. Commencing a diverse range of therapies, including IV vitamin infusions, ozone therapy, hyperbaric oxygen therapy, and high-sensitivity cancer screening, the initiative reflects the resort's commitment to holistic healing and wellness practices, offering guests a comprehensive approach to health and longevity
• In August 2022, HBOT-India launched one of the initial medical-grade hyperbaric oxygen therapy centers in Gurugram, Delhi NCR. The incorporation of hyperbaric oxygen therapy into standard care has shown promising results, reducing major amputation risk by 20-30% and accelerating wound healing rates by 9-10 times, highlighting its potential impact on patient outcomes

SKU-64238